{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaek6tbxrqwy63r46mcm3267v32rapaqpzoasch3p6gtb7yqaisxm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mik4wcmqkht2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreics5ijurmudebej5vxps7gxv7dyj2fdvhcsj4w4d6bylry5kdw7ie"
    },
    "mimeType": "image/jpeg",
    "size": 416951
  },
  "path": "/news/2026-04-leukemia-silenced-gene-mice-treatments.html",
  "publishedAt": "2026-04-02T15:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) have found a way to switch it back on. In a study published in Science Translational Medicine, the team reveals not only a potential new way to treat acute myeloid leukemia (AML) without harsh chemotherapy, but also a promising strategy to study more gene-silencing mechanisms in other diseases.",
  "title": "Leukemia study restores silenced gene in mice. Could it point to new treatments for humans?"
}